GeneDx Holdings (WGS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on GeneDx Holdings (WGS) is Neutral.

The composite score behind that read is -0.13, weighing +0.08 of bullish evidence against -0.35 bearish.

GeneDx Holdings last closed at $73.09, +3.00% on the session.

Against the IVW growth benchmark the position is +2.08% over the forecast window.

The read is built from 11 underlying insights — 5 bullish and 6 bearish.

Agreement across those insights is 55%.

9 graded predictions for WGS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks GeneDx Holdings in the 21st percentile on return on equity, where 100 is best.

GeneDx Holdings is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $2.18B.

StockMap tracks GeneDx Holdings as the 39th largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite GeneDx Holdings ranks 36th of 72 in the group, against a group median of -0.13.